Table 1.
S. No. | Effectors | Encoding gene | Interacting partners | Cyclins | Cell cycle arrest | Type of senescence | References |
---|---|---|---|---|---|---|---|
1 | p14ARF (Ink4a) | CDKN2A | CDK4, CDK6 | D | G1 | OIS, TIS | 24,35,79 |
2 | p15 (Ink4b) | CDKN2B | CDK4 | D | G1 | RS, OIS | 33,80 |
3 | p16 (Ink4a) | CDKN2A | CDK4,CDK6 | D | G1 | OIS, RS, TIS | 32,34,81 |
4 | p18 (Ink4c) | CDKN2C | CDK4, CDK6 | D | G1 | RS, OIS | 82 |
5 | p19 (Ink4d) | CDKN2D | CDK4, CDK6 | D | G1 | OIS, TIS | 16,35 |
6 | p21 (Waf1, Cip1) | CDKN1A | CDK1, CDK2, CDK 4, CDK6 | A, D, E | G1, G1/S | OIS, RS, SIPS, TIS | 22,69,83 |
7 | p27 (Kip1) | CDKN1B | CDK2, CDK4 | D, E | G1, G1/S | OIS, SIPS, TIS | 84,85 |
8 | p57 (Kip2) | CDKN1C | CDK2, CDK3 | E | G1, G1/S | SIPS, TIS | 86,87 |
CDK cyclin dependent kinase, OIS oncogene-induced senescence, RS replicative senescence, SIPS stress induced premature senescence, TIS therapy-induced senescence.